Zobrazeno 1 - 10
of 72
pro vyhledávání: '"xinjun Liang"'
Publikováno v:
Zhongliu Fangzhi Yanjiu, Vol 51, Iss 11, Pp 962-968 (2024)
Colorectal cancer (CRC) seriously threatens people's health and safety, with high incidence and mortality rates. Surgery combined with radiotherapy and chemotherapy is the main treatment method for CRC at present, but the results are unsatisfactory.
Externí odkaz:
https://doaj.org/article/5b1468cf77aa41e4a657ef90a8f7478d
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Colorectal cancer has emerged as one of the predominant malignant tumors globally. Immunotherapy, as a novel therapeutic methodology, has opened up new possibilities for colorectal cancer patients. However, its actual clinical efficacy requires furth
Externí odkaz:
https://doaj.org/article/024c0ea044c443e7ae7a0e8375fd4daf
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Combined large cell neuroendocrine carcinoma (CLCNEC) is a rare neuroendocrine carcinoma, accounting for approximately 10% of large cell neuroendocrine carcinoma (LCNEC). Mainly composed of coexisting adenocarcinoma components, with strong invasivene
Externí odkaz:
https://doaj.org/article/52c72d394cc14737bb315068dab193d0
Autor:
Yanfeng Wu, Mingliang Ren, Rui Yang, Xinjun Liang, Yuanchen Ma, Yong Tang, Lin Huang, Jichao Ye, Keng Chen, Peng Wang, Huiyong Shen
Publikováno v:
Arthritis Research & Therapy, Vol 26, Iss 1, Pp 1-1 (2024)
Externí odkaz:
https://doaj.org/article/fcfa19f3eeb0447893a4887d3fd2574e
Autor:
Yanyan Liu, Haodong Zhang, Wangli Zhang, Lanxin Xiang, Zhucheng Yin, Hongli Xu, Ping Lu, Yifei Ma, Lingyi Xiong, Xiangchen Zhang, Xin Liang, Jing Luo, Xinjun Liang
Publikováno v:
Cell Death Discovery, Vol 8, Iss 1, Pp 1-9 (2022)
Abstract Lung adenocarcinoma (LUAD) is a highly prevalent cancer with high mortality. Immune resistance and tumor metastasis are the pivotal factors for the promotion of LUAD. CircRNAs have been revealed a crucial pre-clinical diagnostic and therapeu
Externí odkaz:
https://doaj.org/article/87d72472f9574919b6499af4eaeb6fc0
Autor:
Zhi Peng, Tianshu Liu, Jia Wei, Airong Wang, Yifu He, Liuzhong Yang, Xizhi Zhang, Nanfeng Fan, Suxia Luo, Zhen Li, Kangsheng Gu, Jianwei Lu, Jianming Xu, Qingxia Fan, Ruihua Xu, Liangming Zhang, Enxiao Li, Yuping Sun, Guohua Yu, Chunmei Bai, Yong Liu, Jiangzheng Zeng, Jieer Ying, Xinjun Liang, Nong Xu, Chao Gao, Yongqian Shu, Dong Ma, Guanghai Dai, Shengmian Li, Ting Deng, Yuehong Cui, Jianmin Fang, Yi Ba, Lin Shen
Publikováno v:
Cancer Communications, Vol 41, Iss 11, Pp 1173-1182 (2021)
Abstract Background Current treatment options for human epidermal growth factor receptor 2 (HER2)‐overexpressing gastric cancer at third‐line have shown limited clinical benefit. Further, there is no specific treatment for HER2 immunohistochemist
Externí odkaz:
https://doaj.org/article/84d42b69d5e24a3c9b4936b33833bf96
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundHigh mobility group protein B3 (HMGB3) is abundantly expressed in a number of malignancies, contributing to tumor cell growth and predicting poor outcomes. More research on the connection between HMGB3 and breast cancer is needed. The progn
Externí odkaz:
https://doaj.org/article/3021386178c643b7b347014450905442
Autor:
Yiqun Li, Yanfeng Wang, Ning Li, Xinjun Liang, Shu Zhang, Qingxia Fan, Xianli Yin, Zhixiang Zhuang, Yunpeng Liu, Jingdong Zhang, Xiaoge Kou, Haijun Zhong, Binghe Xu, Jing Huang, Ningning Wang
Publikováno v:
Chinese Medical Journal, Vol 135, Iss 8, Pp 988-990 (2022)
Externí odkaz:
https://doaj.org/article/ef9952c7921c4dc8befe482fde05f0d6
Autor:
Ying Zhang, Conghui Zhang, Lixi Li, Xinjun Liang, Peng Cheng, Qing Li, Xiaoyan Chang, Kun Wang, Shuai Huang, Yueqiang Li, Yanyan Liu, Gang Xu
Publikováno v:
Cell Death and Disease, Vol 12, Iss 1, Pp 1-17 (2021)
Abstract Inflammation plays a crucial role in the occurrence and development of renal fibrosis, which ultimately results in end-stage renal disease (ESRD). There is new focus on lymphangiogenesis in the field of inflammation. Recent studies have reve
Externí odkaz:
https://doaj.org/article/416a09ec312a40879f81eee7a184cc3a
Autor:
Panpan Meng, Yi-Fan Zhang, Wangli Zhang, Xin Chen, Tong Xu, Sheng Hu, Xinjun Liang, Mingqian Feng, Xiaoqing Yang, Mitchell Ho
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Abstract Glypican-3 (GPC3) is a cell surface heparan sulfate proteoglycan that is being evaluated as an emerging therapeutic target in hepatocellular carcinoma (HCC). GPC3 has been shown to interact with several extracellular signaling molecules, inc
Externí odkaz:
https://doaj.org/article/329ef05cc3ff4f34a6454608732c6a4c